Cargando…

Correction: Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines

Detalles Bibliográficos
Autores principales:	Skalska, Lenka, White, Robert E., Parker, Gillian A., Turro, Ernest, Sinclair, Alison J., Paschos, Kostas, Allday, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4126368/ http://dx.doi.org/10.1371/annotation/2c4b89c1-6d4a-4bf3-9467-9367227d7e74

Ejemplares similares

Induction of p16(INK4a) Is the Major Barrier to Proliferation when Epstein-Barr Virus (EBV) Transforms Primary B Cells into Lymphoblastoid Cell Lines
por: Skalska, Lenka, et al.
Publicado: (2013)

Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV
por: Bazot, Quentin, et al.
Publicado: (2018)

Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57(KIP2)
por: Bazot, Quentin, et al.
Publicado: (2015)

Epigenetic Repression of p16(INK4A) by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP
por: Skalska, Lenka, et al.
Publicado: (2010)

Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression
por: Paschos, Kostas, et al.
Publicado: (2017)

EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency
por: Styles, Christine T., et al.
Publicado: (2017)

BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV
por: Paschos, Kostas, et al.
Publicado: (2012)

How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
por: Allday, Martin J.
Publicado: (2009)

Epstein–Barr virus nuclear antigen (EBNA) 3A induces the expression of and interacts with a subset of chaperones and co-chaperones
por: Young, Paul, et al.
Publicado: (2008)

Epstein-Barr Virus Latency in B Cells Leads to Epigenetic Repression and CpG Methylation of the Tumour Suppressor Gene Bim
por: Paschos, Kostas, et al.
Publicado: (2009)

Requirement for PRC1 subunit BMI1 in host gene activation by Epstein–Barr virus protein EBNA3C
por: Paschos, Kostas, et al.
Publicado: (2019)

Induction of epstein-barr virus (EBV) lytic cycle in vitro causes lipid peroxidation, protein oxidation and DNA damage in lymphoblastoid B cell lines
por: Gargouri, Bochra, et al.
Publicado: (2011)

Epstein-Barr virus nuclear protein EBNA3C directly induces expression of AID and somatic mutations in B cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Establishment of Epstein-Barr Virus Growth-transformed Lymphoblastoid Cell Lines
por: Hui-Yuen, Joyce, et al.
Publicado: (2011)

Dendrosomal nanocurcumin prevents EBV-associated cell transformation by targeting the lytic cycle genes of the Epstein-Barr virus in the generation of lymphoblastoid cell line
por: Cheragh, Mahboobeh, et al.
Publicado: (2023)

Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells
por: Markasz, Laszlo, et al.
Publicado: (2006)

Epstein-Barr Virus- (EBV-) Immortalized Lymphoblastoid Cell Lines (LCLs) Express High Level of CD23 but Low CD27 to Support Their Growth
por: Yap, Hooi-Yeen, et al.
Publicado: (2019)

Extensive Co-Operation between the Epstein-Barr Virus EBNA3 Proteins in the Manipulation of Host Gene Expression and Epigenetic Chromatin Modification
por: White, Robert E., et al.
Publicado: (2010)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2020)

Cellular expression profiles of Epstein-Barr virus-transformed B-lymphoblastoid cell lines
por: Chaiwongkot, Arkom, et al.
Publicado: (2021)

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis
por: Pender, M P, et al.
Publicado: (2009)

EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells
por: Kalchschmidt, Jens S., et al.
Publicado: (2016)

Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines
por: Kotaki, Ryutaro, et al.
Publicado: (2020)

Epstein-Barr Viruses (EBVs) Deficient in EBV-Encoded RNAs Have Higher Levels of Latent Membrane Protein 2 RNA Expression in Lymphoblastoid Cell Lines and Efficiently Establish Persistent Infections in Humanized Mice
por: Gregorovic, Goran, et al.
Publicado: (2015)

Epstein-Barr Virus (EBV)-Associated Haemophagocytic Syndrome
por: Torti, Lorenza, et al.
Publicado: (2012)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

Epstein-Barr virus (EBV)-associated miRNAs are important for the maintenance of EBV transformed B cells
por: Linnstaedt, Sarah, et al.
Publicado: (2010)

Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised
Publicado: (1995)

Epstein–Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
por: Simbiri, Kenneth O., et al.
Publicado: (2015)

Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines
por: Lee, Dong Hyeon, et al.
Publicado: (2006)

Latent Epstein-Barr Virus Can Inhibit Apoptosis in B Cells by Blocking the Induction of NOXA Expression
por: Yee, Jade, et al.
Publicado: (2011)

Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV
por: Venturini, Cristina, et al.
Publicado: (2021)

Correction: Epstein-Barr Virus Genetic Variation in Lymphoblastoid Cell Lines Derived from Kenyan Pediatric Population
Publicado: (2015)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
por: Dugan, James P., et al.
Publicado: (2019)

Epstein–Barr Virus (EBV) Rta-Mediated EBV and Kaposi's Sarcoma-Associated Herpesvirus Lytic Reactivations in 293 Cells
por: Chen, Yen-Ju, et al.
Publicado: (2011)

The Characteristics of Epstein‐Barr Virus (EBV)‐positive Diffuse Large B‐Cell Lymphoma: Comparison between EBV(+) and EBV(‐) Cases in Japanese Population
por: Kuze, Tetuo, et al.
Publicado: (2000)

Perspective: Contribution of Epstein–Barr virus (EBV) Reactivation to the Carcinogenicity of Nasopharyngeal Cancer Cells
por: Wu, Chung-Chun, et al.
Publicado: (2018)

Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases
por: Cui, Xinle, et al.
Publicado: (2021)

Epstein-Barr Virus (EBV) Is Mostly Latent and Clonal in Angioimmunoblastic T Cell Lymphoma (AITL)
por: Bahri, Racha, et al.
Publicado: (2022)

NKG2A-Expressing Natural Killer Cells Dominate the Response to Autologous Lymphoblastoid Cells Infected with Epstein–Barr Virus
por: Hatton, Olivia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_q43d6a2lbp5g0bccrgqop66vdp